ADVANCES IN THE STUDY OF MOLECULAR BASIS OF RESISTANCE TO NEW ANTI-TB DRUGS
- 作者: Peretokina I.V.1, Krylova L.Y.1, Antonova O.V.2, Kholina M.S.2, Gryadunov D.A.2, Nosova E.Y.1, Zimenkov D.V.2
-
隶属关系:
- Moscow Research and Clinical Center for Tuberculosis Control, Moscow
- Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow
- 期: 卷 8, 编号 4 (2018)
- 页面: 577
- 栏目: TUBERCULOSIS AND MYCOBACTERIA: MOLECULAR APPROACH
- URL: https://bakhtiniada.ru/2220-7619/article/view/119227
- DOI: https://doi.org/10.15789/2220-7619-2018-4-6.40
- ID: 119227
如何引用文章
全文:
详细
作者简介
I. Peretokina
Moscow Research and Clinical Center for Tuberculosis Control, Moscow
编辑信件的主要联系方式.
Email: fake@neicon.ru
俄罗斯联邦
L. Krylova
Moscow Research and Clinical Center for Tuberculosis Control, Moscow
Email: fake@neicon.ru
俄罗斯联邦
O. Antonova
Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow
Email: fake@neicon.ru
俄罗斯联邦
M. Kholina
Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow
Email: fake@neicon.ru
俄罗斯联邦
D. Gryadunov
Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow
Email: fake@neicon.ru
俄罗斯联邦
E. Nosova
Moscow Research and Clinical Center for Tuberculosis Control, Moscow
Email: fake@neicon.ru
俄罗斯联邦
D. Zimenkov
Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow
Email: fake@neicon.ru
俄罗斯联邦
补充文件
